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Abstract
This paper presents generic models for the effect of a chemical
toxin on cells forming the tissue of an organ. The models are
illustrative, not specific to organ or toxin. Interactive response of
within-tissue toxin and cells is modeled: cell capability to modify
(metabolize or bind) toxin is represented, as is the alteration of that
capability by toxin presence. Both processes are represented in the
context of simple versions of the cell cycle.
Toxin-cell interaction is explicitly represented in terms of inter-
cell chemical signaling that encourages replacement or repair of
cells. The impact of cell death by apoptosis and necrosis is
represented in terms of within-tissue toxin concentration. The
model is explicitly stochastic, representing inter-cell and toxin input
and within-organ concentration in terms of diffusion
approximations. Explicit mathematical discussion is given of dose-
response function behavior at low doses.

1. Introduction
Application of laboratory toxicology data to environmental and human
problems of risk assessment almost always requires extrapolation of the data
from the experimentally-used dose regimen to the exposure conditions of
practical concern, and from the animal species tested to the species of concern
(usually man). This extrapolation and estimation process is known as chemical
risk assessment. The risk assessment process has undergone considerable
evolution, moving from a qualitative basis for decision making to an increasingly
quantitative basis, and from the use of default assumptions to the application of
mechanistic mathematical models as tools upon which to base decisions. In the
context of determining safe human exposure limits to potentially toxic chemicals,
there are two sub-tasks to be accomplished: estimation of low-dose risk in
animals, and the subsequent conversion of animal risk estimates to human risk
estimates. An authoritative survey of many of the statistical issues and
opportunities is given by Krewski and Franklin (1991).
Extrapolation to low-dose effect, the first sub-task, can be accomplished either
by assuming that biological response varies in a specified mathematical manner
(e.g. probit, logit) with organ host exposure, or by using physiologically-based
pharmacokinetic (PBPK) models to relate organ dose to host exposure; cf.
Krewski and Franklin (1991), chapters 8 and 9; M. Andersen, H. Clewell Jr., and
C. Travis have been prominent in this research area. In the latter approach, multi-
compartment physiological models are formulated using actual tissue volumes
from the experimental and target species and actual perfusion rates to provide
for chemical transport between the compartments. Thus the pharmacokinetics of
high to low-dose extrapolation become amenable to calculation, and external
measures of external dose or exposure can be translated to concentrations in the
target organ (internal dose). Target-organ chemical concentration may be
translated into estimates of risk if a suitable biologically acceptable mathematical
model can be used to relate chemical presence in the organ to harmful outcome.
Such models, called pharmacodynamic, exist for carcinogens, in the form of the
widely-used linearized multistage approximation for cancer dose/response, and
multistage clonal expansion models; cf. Moolgavkar (1988). These models are
based on the general concept that chemical alteration of the cellular genes may
give rise to permanent, heritable changes in the genetic information stored in the
cell nucleus, and lead to phenotypic changes in the altered cells that ultimately
cause the formation of malignant tumors. Simulation is sometimes used to study
stochastic models of carcinogenesis for large numbers of cells; (cf. Bois (1992)).
Unfortunately, analogous dose/response models are not widely available for
toxic responses other than carcinogenesis. The mathematical expression of even
the relatively simple concept of genetic alteration leading to cancer involves
significant simplification of biological reality, and significant mathematical
complexity. This state of affairs is exacerbated when one attempts to describe the
interactions leading to loss of cell function and cell death in tissues of a whole
animal. The multi-layered control and response systems present in an intact
living animal are poorly understood and thus have not yet been adequately
modeled. Nonetheless, these control mechanisms defend against the majority of
toxic effects observed as a result of chemical exposure, and their failure
represents much of what is observed as the expression of toxicity.
This paper describes initial formulations of models for cellular response to
toxic insult. Beginning with a simple Markov model, successive models increase
in biological resolution or refinement as well as mathematical complexity. Our
model formulation takes into account broad aspects of the current state of
knowledge concerning the control and regulation of cellular properties in tissue.
The design of these models is not to provide a detailed description of the
response of specific organs to toxic insult, but rather to begin the process of
mathematically describing recent significant advances in knowledge that have
been made in cell biology, hormonal regulation, and hormetic control mech-
anisms that regulate cell response to toxicants. Some modifications of the model
formulations may be needed to apply them to specific organs; for one thing the
complex geometry of organ architecture is not represented. To have included
complex, three-dimensional relationships between different cell types would
have increased the mathematical complexity considerably. But even in its present
rudimentary state the model is useful for stimulating discussion and suggesting
experimentation, with the goal of furthering the understanding of cellular
response to toxic substances including the effects of tissue-mediated responses
(e.g. mitogenic stimulation). The current formulation of the model, or extensions
thereof, is suitable for experimental evaluation in cell culture if the experimental
conditions are properly chosen and chemical-specific details are added.
We provide the following abbreviated biological background. The tissue
making up organs almost always involves a complex geometrical juxtaposition of
several cell types having specific and often overlapping functions. This tissue
architecture may be maintained by the presence of a nonliving matrix of proteins
collectively known as a basement membrane. Interactions between this membrane
and the cells are known to be critical to its stability as a mature, functioning
entity. The whole of the tissue is permeated by branching blood vessels, each
generation of which is successively smaller; these serve to provide a constant,
stable milieu in which the cells exist. Nutrients, control signals in the form of
specific biomolecules, and xenobiotic chemicals are brought to the immediate
surroundings of the cell by the vasculature in the tissue and cellular metabolic
products; the products of energy metabolism and cellularly derived control
biomolecules are removed from the cellular microenvironment by the same
means.
The state of the cell at any time is a reflection of its age, the summation of the
control chemicals reaching and leaving the cell, the effects of xenobiotic
chemicals present, if any, and the state of the cells surrounding it. Cellular
contact with the surrounding cells and basement membrane act to supply
chemical signals that modulate its activity. A given cell may be (i) nearly
quiescent, (ii) active biochemically, i.e., producing metabolites of absorbed
materials for its own use or for export, (iii) in a state of stress due to shortage or
excess of biochemical molecules, (iv) in a process of programmed cell death
(apoptosis), (v) in the process of dying from chemical insult (necrosis), or (vi)
dividing to form progenitor cells in response to a need to replace cells already
lost; these conditions need not be mutually exclusive at any point in time. Some
specific cells may alter or completely change their observable characteristics in
response to chemical signals. The most well-known of these cells are the
pluripotent stem cells of the hematopoietic system.
The models to be presented here represent some, but by no means all, of the
features mentioned. They provide a basis for proceeding further.
2. Model Structure
In the following sections of this paper we present a sequence of mathematical
models that represent interactions between the cells in an organ's tissue and a
toxic chemical or agent (hereafter called toxin) originating externally and entering
the organ and coming into contact with the cells, possibly in modified form. The
initial models postulate a mature organ with capacity to contain, at most, a fixed
number of cells. Broadly speaking, the organ's cells attempt to remove (e.g.
metabolize or bind) the toxin, but are, to a dose-dependent degree, also affected
by the toxin concentration. We distinguish between cells that are in one of two
stages of the cell cycle: these we call, oversimplifying the true cell cycle,
functional, and dividing (S-phase and mitotic). Functional cells are assumed to be
capable of removing toxin, but are also susceptible to premature death because of
the toxin's action. Dividing cells are in the process of DNA replication and actual
mitosis, here splitting into two daughter cells; while in this stage the cells are
assumed incapable of removing toxin. However, toxin presence is assumed to
affect the cell cycle, e.g. by shortening the functional, and lengthening the
dividing, stages. The model proposed emphasizes inter-cellular signaling: when
a cell dies, i.e. ceases to function, it effectively requests one other functioning cell
to divide to produce its replacement. It is biologically plausible that signaling
occurs only to neighboring cells, but the present model, being without spatial
characteristics, does not literally recognize this restriction. Also, signals are
assumed to be specific: one signal is emitted per cell death, so eventually one
replacement occurs. Alternative formulations are sometimes plausible and are
easily studied.
3. Single-Stage Markov Model
We now present several alternative simple Markov models for cell-toxin
interaction, emphasizing the representation of signaling. Although cells can age
and exist in different stages of functionality we omit an account of this at first,
but return to it later.
Let D(t) represent the number of functional cells in the organ at time t, and
M(0 the number of dividing (mitotic) cells. If a functioning cell that dies
immediately induces another to begin division (instant signaling) then
Co = D(t) + 2M(t) (3.1)
where Co is the maximum organ size, here assumed constant; realistic
elaborations are possible. Note that organ size is, strictly speaking, D(t) + M(f),
which is the number of cells present at time t; Co acknowledges that space for all
cells must leave room for each cell currently in mitosis to eventually become two
differentiated cells. We describe {D(0, M(f)} as a birth and death process in
continuous time, with D(t)e (0, 1, 2, ..., Co). Typically Co is large, i.e. of order
10 10-10 12 for mature humans, and this will be exploited to carry out an
asymptotic analysis.
Let T(0 denote the concentration of toxin in the organ at time t. We represent
{T(0} as a diffusion process whose drift and diffusion coefficients are both
influenced by D(t) so as to represent metabolic or binding action, hence toxin
removal, and by the toxin input to the organ, xtf), as well as the instantaneous
concentration, T(t), itself.
In the following we describe specific models, beginning with the most simple
and (potentially) least realistic, but also the most parsimonious. We explicitly
include the effect of inter-cellular signaling.
3.1 Cellular Signaling
Suppose a cell dies from some cause: apoptosis or necrosis. The effect of its
signaling to other cells for replacement can be captured by postulating that a
ghost (release of growth factor) of the newly-dead cell now exists, the function of
which is to find and interact with a neighboring live cell, inducing that cell to
divide. The ghost then disappears after its purpose is served. One can thus
represent the delay in mitotic response to cell death by adjusting the ghost's
search rate for functional cells.
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The following describes a possible Markov generator that includes the
signaling (ghost) influence. Let G(t) denote the number of signals present in the
organism at time t, and introduce the constraint
Co = D(r) + G(0 + 2M(0. (3.2)
The following then describes the possible transitions allowed to occur in a small






t + dt Probability
-4 D(t) - 1, Git) + 1M0 X*D(t)dt
T(t) + 8*dt + odW(t)
(cell death, signal creation)
-> D(f) - 1, Git) - 1, Mit) + 1 6 *G(t)(D(t)/C )dt
7X0+ 6*dt + odW(t) (3.3)
(cell signaled to divide, signal
disappears)
-» D(t) + 2, G(0, M(f ) -
1
n*M(t) dt
T(t) + 8*dt + odW(t)
(two newly-divided cells emerge)
All rates of cell transition, namely A*, &\ and (i are presumed to be influenced
by current toxin concentration, 7^0- In turn, the latter is influenced by the
metabolic or binding capability of the cells to remove toxin; the net mean
increase of toxin in the short run is 6*(T(t),D(t),x(t)). Our subsequent analysis
does not, in principle, depend upon specific functional forms for any of the above
parameters; adequate smoothness and differentiability is assumed where
necessary. When specific functions are required we shall use these:
£(T(t)) =x/T{t) (3.4,a)







Note that it has been assumed that increased toxin level increases cell death rate,
decreases the rate of completing mitosis, and slows the rate at which ambient
signals reach their destinations. The net effect is to reduce the number of






where in the latter T*(0 represents toxin input rate to the organ, and the
remaining term v (T(f)D(f)/Co)/ 1 + k* T(t)\ represents the toxin concentration
rate-limited (Michaelis-Menton) reduction by functional cells.
It has been observed that the realistic effect of toxin presence on A*, /i*, 0*, etc.
at time t may involve the entire past history of such exposure, e.g.
A (t) = X (T(x),a<x<t); the explicit function may be illustrated by the form
A*(0 = exp j'/(T(x)dx) A further model enhancement would recognize that
toxin presence in the organ may result in cells that complete completing mitosis
giving rise to damaged cells, e.g. possessing DNA adducts. These cells now
become susceptible to repair.
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3.2 Differential Equations For Deterministic Approximations
Let Co denote the number of spaces/holes that cells may occupy. Then
Co = D(f) + Git) + 2M(t) (3.6)
since the cells in division potentially require two holes. Assume that if Co» 1
then
D(f)/C -» ait), Git)/Co -* yit), IXfl/Co -* Pit) (3.7)
in probability as Co—»°° where the latter functions are O(l). The following
differential equations result from direct manipulation of (3.3):
£21 =
-Xa{t ) - 6a(tMO + 2/i(l- a(() - y(())|
;
(3.8)
the last term occurs by virtue of (3.6). Also,
^P = Xa(t)-6a(t)y(t) (3.9)
at
*l = 5 =T-^- (3.10)
dt 1 + Kp
We re-emphasize that all parameters are implicit functions of (current) toxin
level, T{t), and possibly also absolute time, t, which can be viewed as the age of a
mature organ, rather than an individual cell. This latter step is not taken in this
paper.
Note that in (3.8), (3.9), (3.10) the original parameters of (3.3) must be scaled:
KiTit)) is replaced by Xifiit)), e*(7X0) by 0(#O), /i*(T(r)) by nipit)), v\Tit)) by
viPit)), t* by tCo, and k by kCq.
In Section 6 such scaling is exploited more extensively to deduce stochastic
behavior of system state values.
3.3 Solution Without Toxin Input
Suppose no toxin input exists, so T(t) = 0, Vf > 0. Then a steady-state solution
to (3.8) and (3.9) may occur: set derivatives = and solve the resulting equations
to find
y = \, provided 0<-<l (3.11)6 6
« =4f^}. (3,2)
The latter implies (i) that the larger the signal activity rate, 6, the smaller the
ambient signal population, and the more quickly does signaling induce another
cell to begin division; furthermore (ii) if 8» A, the death rate, signifying highly
efficient signaling, then a —
»
n/(2k + /i), which is equivalent to thinking of cells as
behaving in pairs: once division completes the two daughters effectively compete
to die (rate 2A).
Although the equations (3.8) and (3.9) are non-linear and apparently cannot
be solved explicitly one can obtain an approximate time-dependent solution as
follows:
(a) assume ){t) quickly reaches steady state, so
y(t) = X/e; 0<t (3.13)
This is a standard and useful approximation technique often invoked in
biochemical kinetics problems that is variously abbreviated the quasi-steady-state
assumption (QSSA) or the pseudo-steady-state hypothesis (PSSH); see Segel and
Slemrod (1989) for a careful exposition of its rationale. The QSSA approach gives
rise to the classical Michaelis-Menton used widely in pharmaceutical kinetics and
compartment models; it already appears implicitly in our (3.5) and (3.10).
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(b) introduce (3.13) into (3.8) to find the approximation a(t )
:
da{t)/dt = -(2A + n)a + n(l - X/6),
the solution of which is





3.4 Dose-Response for Small Steady Toxin Exposure
Of interest in risk analysis is the behavior of the dose response curve for small




t = 0' dr
and-^
t = dr T = 0"
Suppose tit) = t = t ~ 0, a constant, and that exposure has proceeded for some
time so that a steady-state condition has been reached; this is modeled by letting
M0 =M0 =^ = o iR (3g) _ (310) To stud the dose-response for r«0,
dt dt dt
j r
differentiate (3.10) with respect to t using the function S in (3.5) (drop subscript
"o" for convenience)
dvdp ap vda p va dp
|
vccp dp
dpdrl + icp dr 1 + kP 1 + tcp dr (1 + tcp)2 dr
(3.16)
Since p = for t = 0, equation (3.6) yields for the (scaled) rate of toxin
concentration at low exposure
** t = va r = v^(i-|) (3.17)
This shows explicitly how low-dose toxin level in the organ tissue increases as a
function of cell-cycle parameters X and \i, signaling efficiency, 6, and toxin
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metabolic or binding rate v. All of these parameters are evaluated at very low
(zero) toxin levels.
Next consider steady-state rate of change of scaled functional cell fraction,
da
—
- = ax = a a • pr ; this is the slope of a dose-(functioning cell count) response
ox H
curve at very low levels of toxin. If (3.12) is differentiated and some
rearrangements made, and if y= XI 6 as in (3.11), then
H =hV(2 + A/M + 2(l-y)) + ^(2A(l-y)) + ^(2A + /z)(/z/g)y] ^ 2 . (3.18)
Since /?T > 0, the sign of Ox is determined by the above linear combination of the
derivatives of the cell cycle and signaling parameters A, fi, and 6 at x, and hence
(3, equal to zero. Note that if the illustrative relations (3.4) are invoked as given,
then ap < 0, hence a? < so a small increase in toxin induces a decline in the
number of functioning cells; this is intuitively acceptable. However, a change in
sign of any of the parameters' derivatives is capable of reversing the sign of the
slope of the dose response curve, thus representing a tendency for hormesis at
low dose.
4. Models with Cell Aging
In this section we generalize the models of the last section to allow cells to
age, and hence exist in possibly different stages of functional effectiveness.
We restrict attention to just two age stages, which we term new (n) and old (o),
distinguishing them by subscript. An arbitrary number of such age states can be
introduced, but at the cost of increasing the number of parameters.
Let Dn (t) (respectively D (f)) represent the number of new (respectively old)
cells at time t. M(t) represents the number of dividing (mitotic) cells at time t and
G(t) the number of ambient signals or ghosts as before. The spatial constraint is
12
Co = Dn(t) + D (t) + Git) + 2M(f).
Here are the transition probabilities assumed:
Signaling Model with Age Dependence
(Markov Generator)
(4.1)
t t + dt
Dn(t),Doit), -> Dn(t)-l,D (t)t G(t) + lM(t)
Git), Mit); Tit) + 8*dt + odWit)
T(t) (new cell death, signal creation)
-> Dnit),D it)-l,Git) + l,Mit)
Tit) + 8*dt + odWit)
(old cell death, signal creation)l
-> Dn it) - 1,DM Git) - l,M«) + 1
Tit) + 8*dt + odWit)
(new cell signaled to divide,
signal disappears)
-> Dn it) f D it) - 1, G(t) - 1, M(0 + 1
Tit) + 8*dt + odWit)
(old cell signaled to divide,
signal disappears)
Dnit) + 2,D it),Git),Mit)-l
Tit) + 8*dt + odWit)
(two newly-divided new cells
emerge)
-> Dnit) -h Doit) + I, Git), Mit)
Tit) + 8*dt + odWit)




dn Git)iD nit)/C )dt
eo Git)iD it)/Co)dt (4.2)
tfMit) dt
<t>*Dnit)dt
Once again all rates of cell transition, namely aJ,, X , 6n , 6 , /z* are presumed
to be influenced by current toxin concentration. In turn, the latter is influenced by
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the metabolic capability of the cells to remove toxin, 5*(T(0, Dn (t), D (t), tit)).
When specific functions are required, we shall use for illustration
5-(m(wwo)=Afv;M-v;« (4 .3a)










ti*(T{t)) = tioe-^T^ (4.3e)
The form of (4.3b) permits the adjustment of organ toxin concentration-caused
cell death rate to be flexibly adjusted; if Xn \ < the inner bracket must have its
sign reversed: ( )+ . As before, the above forms are hypothetical.
4.1 Differential Equations for Deterministic Approximations
Let Co denote the number of spaces /holes that cells may occupy. Then
Co = D n (O + Do(O + G(0 + 2M(0.
Assume that
Co <-0 M) L
(4.4)
in probability as Co —> °°- The following differential equations result from direct
manipulation of (4.2) with scaled rate functions
^^ = -[AB
+0]an(O-^a„(Oy(O + 4l-«n(O-ao(O-y(O] (4.5)
fSM =






e a (t)]y(t) +W) + V*„(<) <47>
These equations can be solved numerically, but not in closed parametric form.
4.2 Solution Without Toxin Input
Suppose no toxin input exists so T(t) = 0, t £ 0. Then a steady-state solution to
(4.5) - (4.7) may occur; set derivatives equal to obtaining the following
equations.
=





+ <t>an -6oaoY (4.10)
= [-Bnan - eoa ]y +^ + X a . (4.11)
Equation (4.10) yields
a„=(l/0)[Ao + oy]ao . (4.12)
Substituting (4.12) into equation (4.11) yields
o = [-dn (y<p)[x + e y] - e ]r + {K[{V<t>\K +Ml + A*) (413)
after dividing through by ocq.





- y[en (y<t>)x +e -K{Vt%] + [(V#) + i]V (4.14)
Thus y satisfies a quadratic equation. Let y be the positive solution to the
equation. If An(0) = 0, as in (4.3b)
{k^Hk^)2 +*ki
yo=
_U_* nj ,V w ^ ^ (415)
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If y < 1, then y= y . If y > 1 then ambient signals and not functional cells
dominate the organ, which in reality would be long defunct even without toxin.






then y < 1.
To find olq equation (4.9) is used. Putci = (l/#)Uo + Oofi. Then
/41 ~ To] = {% + 0)q + 0»tt + /4ci + l]}a = {2A + //[q + 1] + 2A„c1 }or .
Thus,
and




4.3 Dose-Response For Small Steady Toxin Input
As mentioned earlier, the behavior of an organ-level dose-response curve for
small values of toxic dose is of interest in risk analysis. In this section we indicate
that the derivative of various cellular-level responses with respect to t may be
evaluated at x = 0.
If t = then P = 0. Set the left-hand side of (4.8) equal to zero, then
differentiate the right side with respect to x. After setting p - 0, this yields
= l-[vnan + voao]-£
Thus
dp




as is physically plausible.
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It may be shown by further differentiation that under the specific
parameterization of (3.4), or suitable alternatives, all derivatives of long-run
cellular-level response can be explicitly evaluated at t = 0, as was shown earlier.
The complex details are omitted here.
5. A Model with Cell Aging and Organ Tissue Growth
In this section we generalize the previous model to allow cells to
spontaneously enter mitosis and multiply, thus effectively increasing the organ
size, where the latter is defined as the number of cells in existence, in either state.
In the previous section cell replication only occurred to replace other cells that
previously have died, possibly as a result of toxin action.
Consider the region to be occupied by cells to consist of spaces /holes that
may be filled by cells. Let Co be the maximum number of such holes, in this case
the number in an essentially mature organ. Initially not all such holes are active,
for the organ is immature and hence growing. Hence let C(t) be the number of
active holes at time t , while Co - C(t) are currently quiescent or inactive. Now,
generalizing the previous setup, let the current number of active holes/spaces be
C(t) = D n (t) + D (t) + Git) + 2M(t) (5.1)
and augment the previous model to allow C(t) to gradually grow, although
remaining bounded by Co-
5.1 Organ Growth Stimulated by Signaling
In this model the presence of inactive holes /spaces effectively encourages the
active cells, D n (t) and D (t), to increase the number of signals and hence the
number of active spaces capable of accomodating cells. We are implicitly
modeling the competing effects of positive and negative, or inhibitory, growth
factors.
17




Dn(t\ D (t), -+ Dn it), D it), Git) + 1, Mit), Cit) + 1
Git), Mit), Tit) + Sdt + odWit)
dt) Tit) (a quiescent cell space becomes
active, signal creation)
-» Dn it) - 1, D it), Git) + 1, Mit), Cit)
Tit) + 5dt + odWit)
(new cell death, signal creation)
-> Dnit), D it) - 1, Git) + 1, M(0, C(0
Tit) + 6dt + odWit)
(old cell death, signal creation)
-> D„(f) + 2, Do(0, G(0 + 1, M(0 - 1, C(0
Tit) + 6dt + odWit)
(two newly-divided cells emerge)
-» D„(f) - 1, Do(0 + 1, G(0, Mit), Cit)
Tit) + 8dt + odWit)
(new cell becomes old)
-> Dn it) - 1, D (f), Gft) - 1, M(0 + 1, Cit)
Tit) + Sdt + odWit)
(new cell signaled to divide,
signal vanishes)
-> Dn it), D it) - 1, Git) - 1,M(0 + 1, C(0
7X0 + Sdt + orfW(0
















Once again, all rates of cell transition, namely, A„, A , €t, 0*, \i, £„, <f; are
presumed to be influenced by current toxin concentration. When specific
functions are required we shall use
&(T(t))=S°M<<im
in addition to those of (4.3 a-e).
(53)















m y(0 + Xnan (0 + A a (f ) + [S a (t) + Snan (t)][l
- T)(t)] (5.7)







6. Stochastic Differential Equation Models
The size of the state space makes the time-dependent behavior of the
continuous-time Markov chain models of Sections 3-5 difficult to study. One
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approach to studying the behavior is by Monte Carlo simulation; cf. Bois, et al.
(1992). Another approach, adopted here, is to approximate the continuous-time
Markov chain model by a diffusion process. Note that the continuous-time
Markov chain model has absorbing states; for example, any state with D n (t) +
D (t) = is absorbing. Of course no self-respecting organ would ever start life in
such a state, and a living organ would presumably die from other unmodeled
causes long before such a state is reached, i.e. when Dn (t) + D (t) < D, some lower
limit. Barbour (1976) discusses how long and over what ranges the underlying
continuous-time Markov chain is approximated by a diffusion process of the type
we derive; see also discussion to McNeil and Schach (1973). Stochastic
differential equation models can be written for all the models of Sections 3-5.
We will illustrate our approach by writing down a system of stochastic
differential equations for the multivariate process (Dn (t), D (t), G(t), C(t), T(0) for
Markov generator (5.2). The system of stochastic differential equations is as
follows; as explained subsequently, the dW-terms are normally distributed.
dDn (t) = -4(T(t))Dn (l)d(-e;(r(())G(()(D„(()/C(0>it
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^ = ^(T(0,Dn (0,Do (0,T*(0^}(drift)





and (w^f)} are independent standard Brownian motions; each dW(0-term is
thus Gaussian with mean zero and variance dt.
Setting the constant e = 1 lets the variances of the change in the number of
active cells, ghosts in identified states, and active spaces be equal to the mean
respective changes; this represents Poisson variability. Setting the constant £ > 1
implies that the variability is larger than Poisson variability. This additional
variability may be the result of inhomogeneities in the organ that are not
explicitly modeled; cf. Bass, Robinson and Bracken (1978) for discussion of a
distributed liver model with random inhomogeneities. Such overdispersion is
frequently encountered in practice, and may be accounted for parsimoniously as
we do; see McCullagh and Nelder (1983).
We assume that as Co —> °°
c Co Co
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in probability and rewrite Dn (t), D (t), G(t), C(t), and 7X0 as follows.
Dn (t) = C an (t) + Jq;xn (t) (6.7a)
D (t) = Coa (t) +^X (t) (6.7b)
' G(0 = 0)7(0 + VQ)xg(0 <6 -7c>
C^^Co^ +^X^t) (6.7d)
T(f) = Coi3(0 +^OyW (67e)
<***(*) = Cqt(0 +^ardWT (t) (67f)
The transition rates will be scaled and expanded as follows:
4(r(0)= A„(r(f)/c )= a,0W))+KiPCW')/^ +0(1) (6.8a)
A;(T(()) = ^(T(0/Q,) = A (/5(<)) + Ji(«0)*(0A/5> + 0(1) (6.8b)
/i*(r(t))
=
m(t(0/co ) = mWO) +nW))n)l-fo + o(i) (6.8c)
<£(T(0) = e„(T(t)/c ) = e„(^(<))+ ^(^(())v(()/VQ + o(i) (6.8d)
0'o{T(>)) = *„C(0/C6) = *<,(/5(0) +%(m)n')/^ + O(l) (6.8e)
«;(T(0) = ^(T(0/C ) = fe,(«0)+«;(/((0)V(0/>/Q+O(l) (6.80
&*(r(0)
= lo(r(()/c ) = S,WO) +£(/»(0)*(0A/Q + o(i) (6.8g)
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$*(D„(t),Do(f),T(0, % (*)) = c 5(dm(0/c ,do(0/q, ,t(0/c , t (O/Co)
= Cb5(aB (f),ao(0,/5(*M0) (6.8h)
+Co5i Siffi + Cb^i^ +0^^ + 0(1)
ar(DB(0,Do(0,r(0,T*(0) = VCo^r(D„W/C ,D (f)/Q> ,T(0/Q> , t (0/q,)
(6.8i)
= VQar (an (0,ao(0^(0^W) + 0(1)
Dividing equations (6.1) - (6.5) by Co, scaling and substituting (6.7a) - (6.7 f)
results in a system of equations involving the deterministic components an (t),
«o(0, )0), 77(0, and p(t) and the corresponding stochastic components Xn (t), X (t),
Xg(t), Xc(0, and Y(t). See Appendix 1 for details.
6.1 Second Moments
The stochastic differential equations (A.l) - (A.10) of Appendix 1, derived for
the stochastic disturbances, can be written in matrix-vector form as
dZ(t) = Aft)Z(f) + B(0 dmt) (6.9)
where in the present example Z is a 5x1 column vector, A is a 5x5 matrix, dW(t) is
10x1 column of independent Gaussian noise terms and B(0 is a 5x10 matrix.
It follows from theorem (8.5.5) of Arnold (1974) that
d|-E[z?(0] = 2XA i; (0E[z i (0Z








Thus,the approximate distribution ofDn(t), (respectively D (t), G(t), C(t),T(t)) is
normal with mean Coan (t), (respectively Coctoit), Coy(t) CnrKO, Cop(t)) and variance
C e[x2 (0], (respectively C E[xo
2(0],C E[4(f)],CoE[xc
2 (0],CoE[v2 (0])- The
approximate covariance of Dn (t) and D (t) is CoE[Xn (t)X (t)], etc.
We point out that exactly equivalent results can be obtained by introducing
transforms for the state variables, computed by taking conditional mathematical
expectations of exponential functions of the Markov generators. This is the route
followed by McNeil and Schach (1973); see also Carpenter, Gaver, and Jacobs
(1993). The transform approach provides a verification that the asymptotics
described here actually lead to limiting Gaussian distributions and to Ornstein-
Uhlenbeck processes. See Ethier and Kurtz (1986) for a more rigorous discussion.
The approach taken here, while heuristic, is intuitively appealing and reaches the
same ultimate conclusion.
6.2 Numerical Examples
In this section we present three numerical examples.
a. Constant Rate of Input of Toxin
We assume chronic dosage of the organ by toxin that is delivered there at
constant mean rate but with substantial randomness around that mean.
Figures 1-5 depict the time variation of the expected numbers of new cells,
of old cells, of total number of active (new plus old) cells, number of signals
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(ghosts), and amount of toxin plus/minus two population standard deviations.
There is no organ growth. The initial conditions are the limiting moments with
no toxin input. The toxin input rate 0.2 units/cell for all time. The new cells
without toxin have mean time 100 before transitioning to old. The old cells have
mean lifetime of 100 without toxin. The number of cells in the organ is 1.5x10s .
The organ size is about that of a mouse liver. Since the cells in a mouse liver have
a mean lifetime of about 200 days; cf. Bois, et al. (1992), the above is consistent
with mouse liver behavior. The MATLAB 4th and 5th order Runge-Kutta-
Fehlberg numerical integration method was used to obtain the solutions. The
MATLAB plotting algorithms were used to produce the figures.
There is extra Poisson variability: £ = 104 .
Note that the total mean number of active (new and old) cells decreases as the
result of toxin input, as seems intuitively reasonable. The mean number of new
cells initially decreases, but eventually increases to a new steady-state value
which is larger than the value with no toxin. The mean number of old cells
initially increases briefly, but then decreases to a new steady-state value below
the value for no toxin. The mean amount of toxin and the mean number of
signals (ghosts) both increase to new steady-state values.
The above hypothetical example illustrates how model parametric inputs
translate into an account of the dynamics of subpopulations of cells. The details
of the transition from one steady-state situation to another are of possible interest
in that the organ may be in jeopardy during that transitional period because of,
for example, new cell initial downward fluctuation. The effect on organ mortality
is, however, not explicitly modeled.
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b. A Toxin Pulse or Bolus Dose
Figures 6-10 display the mean number of new cells, old cells, active cells
(new and old), signals (ghosts) and amount of toxin plus and minus 2 standard
deviations for the case in which the rate of toxin input is 0.2 per cell for the first
50 time units and thereafter. Once again there is no organ growth. The initial
conditions are steady-state values when there is no toxin input. Note that the
number of active cells decreases during toxin input, then increases and slightly
overshoots the steady-state value with no toxin before returning to its steady-
state value with no toxin.
c. Organ Growth
The model of Section 5.1 and (6.1) - (6.5) is initialized with the steady-state
values for the second moments with no input of toxin. However, only 1/2 of the
available spaces are active (may contain cells); the steady-state mean of new and
old cells and ghosts for no toxin input are multiplied by 1/2 and used as initial
values. Figures 11-15 display the mean numbers of new, old, and active cells,
ghosts, and active spaces pius/minus two standard deviations for the case of no
toxin input and parameters £n/o = 0.5, £n/ i = 0.5, <f^o = 1/ <5o,l = 0.5. The mean
number of active spaces is the maximum number by time 20. However, the mean
number of old and new cells is still adjusting by time 100. The mean number of
old cells initially decreases before increasing. The mean number of new cells
initially increases before decreasing.
The present model might be useful for describing the aftermath of a partial
hepatechtomy: about one-half of a mature liver remains, and grows back with
subpopulations of cells responding as shown. Note that, according to the present
model in Figure 12, the organ must withstand an early signal to old cells to
undergo substantial depletion to enter mitosis and bring forth replacements; the
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latter are the new cells depicted in Figure 11. It may be that the sudden depletion
of old cells to their low point at about t - 6 (Figure 12) actually puts the organ in
jeopardy.
Figures 16 - 21 display the mean number of new, old, and active cells, ghosts
and active spaces plus/minus two standard deviations for the same parameters
as used in Figures 11-15 but with two levels of toxin input. The dashed lines
correspond to no toxin input. The solid lines correspond to a constant toxin input
of 0.2 per cell per unit time. The graphs with positive toxin input have the same
general shape as those with no toxin input. The mean number of new cells is
initially less for a positive toxin input than for no toxin input. However, by time
100 the mean number of new cells with positive toxin input is becoming larger
than that for no toxin input.
The effect of positive toxin input on the mean number of old cells is that it is
initially larger than that for no toxin but by time 100 the mean number of old
cells with positive toxin is less than that for no toxin. The effect of positive toxin
input on the mean number of active (old and new) cells is to decrease it and
delay its approach to a steady state value. The mean number of ghosts is larger
with positive toxin input. Positive toxin input delays the overall growth in the
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This appendix provides the detailed asymptotic development of both the
deterministic approximation (5.5) - (5.9) but also for the stochastic components
introduced in (6.7). Start by introducing the normalization (6.7) into (6.1) - (6.5)
and divide by Co- The following results are obtained:
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The terms of order 1 in (A.l) - (A.5) yield the deterministic equations (5.5)
(5.9).
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The terms of order 1/VCo in (A.l) - (A.5) give the following stochastic
differential equations for the noise terms.
-e„(«0)x,(()^-^(«/))rW^v(( )
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(A.8)
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